Jump to any asset
849 assets, updated daily
As of September 16, 2026, GE HealthCare Technologies Inc. (GEHC) trades at $64.07. CleaRank Financial AI rates it Buy with a fair value of $83.00, 29.5% above the current price. Wall Street's consensus target is $83.00 across 19 analysts. RSI at 4 is in oversold territory, and the price is below its 50-day average of $68.26.
GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. NASDAQ
$64.07
-0.1800 (-0.28%)
At close: Sep 15, 4:00 PM EDT
AI Analyst Consensus
74 / 100
GE HealthCare Technologies Inc. (GEHC) is currently trading at $64.07, below its 50-day and 200-day moving averages ($68.26 and $72.42), indicating a bearish technical trend. However, the company exhibits strong fundamental health with a profit margin of 9.33% and a return on equity of 19.38%, comparing favorably to sector averages. Insider activity shows a moderate buy signal, with $6.4 million in net purchases, suggesting management confidence. The stock's current valuation is attractive relative to its growth prospects and sector peers. With a P/E ratio of 14.80, it trades at a discount to the sector median of 31.9. Analysts maintain a consensus 'Buy' rating with a median price target of $83.00, implying a significant upside potential. The primary risk remains the current oversold technical condition and the need for a sustained upward trend to confirm a reversal.
GEHC Price Analysis
Market Metrics
Open
$64.20
Day Range
$63.61 to $64.64
Prev Close
$64.25
Volume
4.17M
52-Week Range
$58.75 to $89.77
Market Cap
$28.94B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Trading at a notable discount to sector peers (-54%), which may indicate undervaluation or specific company headwinds.
GEHC Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 2 quarters, GEHC beat estimates 1 times. The stock rose 1 times the next day. Price tends to react positively to beats.
GEHC Analysis
Company's Health
4/5
12-Month Analyst Target
+29.55% Upside
Median of 19 analysts (12-month)
$83.00
AI Technical Analysis
GE HealthCare Technologies Inc. (GEHC) is currently trading below its 50-day and 200-day moving averages ($68.26 and $72.42), signaling a bearish trend. The Relative Strength Index (RSI) is at an oversold level of 4.28, suggesting a potential for a bounce, though momentum indicators like MACD remain negative. Key support levels are not clearly defined due to the oversold RSI, but the current price of $64.07 is approaching previous lows. Volume has been above average recently, indicating increased trading activity. The chart structure suggests that a sustained move above the 50-day SMA would be required to signal a shift in the short-term trend.
ProTips
- Insider buying totaling $6.4 million suggests a moderate level of confidence from management in GE HealthCare Technologies Inc. (GEHC)'s future prospects.
- GEHC's oversold RSI of 4.28 indicates a potential short-term buying opportunity, but confirmation through a sustained move above its 50-day SMA ($68.26) is advised.
- Consider the competition in medical devices; while GEHC is currently undervalued, innovation and market share shifts could impact its long-term trajectory.
Key Catalysts
Bullish
Moderate Insider Buying Signal
Insiders have made net purchases totaling $6.4 million, indicating a moderate level of confidence in the company's future performance.
Source: Insider Trading DataBullish
Analyst Price Target Upside
The median analyst price target for GEHC is $83.00, representing a potential 29.5% upside from the current price of $64.07.
Source: Wall Street AnalystsBullish
Oversold RSI Suggests Potential Reversal
The current RSI of 4.28 is in oversold territory, which historically can precede a price rebound.
Source: Technical AnalysisBearish
Bearish Technical Trend
GEHC is trading below its 50-day and 200-day moving averages ($68.26 and $72.42), indicating a prevailing bearish trend.
Source: Technical AnalysisMarket Outlook
The base case scenario for GE HealthCare Technologies Inc. (GEHC) anticipates a recovery towards its median analyst target price of $83.00 over the next 6-12 months, driven by its solid fundamentals and attractive valuation. The company's consistent profitability and moderate insider buying provide a foundation for potential upside. Upside catalysts include a sustained technical breakout above key moving averages and continued positive earnings surprises. Conversely, a failure to overcome current technical resistance or increased competitive intensity could lead to a downside scenario, potentially testing lower support levels around $30.46 as indicated by long-range projections.
Key Statistics
| Market Cap | 28.94B |
|---|---|
| P/E Ratio | 14.80 |
| EPS (TTM) | 4.34 |
| Dividend Yield | 0.22% |
| 52 Week High | 89.77 |
| 52 Week Low | 58.75 |
GE HealthCare Technologies Inc. (GEHC) demonstrates solid fundamentals, with a net profit margin of 9.33% and an operating margin of 14.98%, exceeding its return on equity of 19.38%. The company's price-to-sales ratio stands at 1.36, which is significantly lower than the sector average of 3.7, indicating a potentially undervalued stock. The debt-to-equity ratio of 0.94 is in line with the sector average, suggesting a manageable debt load. While revenue growth has been modest at 5.8%, the company's profitability and valuation metrics present a strong case for investment, especially when considering the analyst price targets that suggest considerable upside.
Earnings & Growth Analysis
GE HealthCare Technologies Inc. (GEHC) recently reported earnings for the quarter ending June 2026, with an EPS of $2.84, slightly beating the estimate of $2.80 by 1.43%. This positive surprise was accompanied by a significant price increase of 12.15%. The prior quarter's earnings showed a slight miss, but the overall trend indicates consistent profitability and the ability to meet or exceed analyst expectations, supporting the current 'Buy' consensus.
Key Risks
The primary risk for GE HealthCare Technologies Inc. (GEHC) is its current bearish technical positioning, trading significantly below key moving averages with an oversold RSI. Competitive pressures within the medical devices sector could also impact future growth and profitability. Additionally, any failure to meet forward-looking revenue growth estimates of approximately 5% could dampen investor sentiment.
Technical Indicators
| RSI (14) | 4.28 |
|---|---|
| MACD | -1.55 |
| SMA 50 | 68.26 |
| SMA 200 | 72.42 |
RSI
Oversold
SMA Cross
Bearish
Price vs SMA
Bearish
MACD
Bearish
Moving averages show a lagging Death Cross (50-day: $68.26, 200-day: $72.42), price is trading below the 50-day SMA, RSI at 4.3 suggests oversold conditions; potential bounce setup.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.51
Moderate correlation
Nasdaq 100 (QQQ)
+0.40
Weak correlation
Bitcoin (BTC)
-0.02
Weak correlation
Gold (XAU)
+0.06
Weak correlation
Check Custom Correlation
How does any other asset move with GEHC? One year of daily closes, Pearson correlation.
Try
GEHC Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Long entry pick an entry style
Conservative
$62.79
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$64.07
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$60.72
MAX LOSS
-3.3%
Volatility-Adjusted Stop Loss
Calculated based on RSI (4.3) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$65.93
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$69.07
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$72.21
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for GEHC is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 16, 2026.Growth of $10,000
A $10,000 investment in GEHC in July 2023 would be worth about $8,275 today, compared with about $16,627 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in GEHC today could grow to about $13,148 by 2036 in the base case, with a bull case near $50,651 and a bear case around $3,413. Projections are statistical simulations, not guarantees.
GEHC Stock Price Prediction: 2030
CleaRank's simulation projects a price near $71.48 for GEHC by 2030 in the base case, from $64.07 today (1.1x over 4 years). The downside path ends near $30.46. These are outcomes of a Monte Carlo simulation run on GEHC's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $42.99 | $65.85 | $101 |
| 2028 | $37.02 | $67.67 | $124 |
| 2029 | $33.23 | $69.55 | $146 |
| 2030 | $30.46 | $71.48 | $168 |
| 2031 | $28.31 | $73.47 | $191 |
| 2032 | $26.56 | $75.50 | $215 |
| 2033 | $25.11 | $77.60 | $240 |
| 2034 | $23.87 | $79.75 | $266 |
| 2035 | $22.80 | $81.97 | $295 |
| 2036 | $21.87 | $84.24 | $325 |
Method: 10,000 simulated price paths using GEHC's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
GEHC Insider Trading Analysis
Bought
$6.4M
8 Transactions
Sold
None
No open-market sells
Insiders
21
Active Traders
Avg Transaction
$802.9K
Moderate size
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 15, 2024 | MAKELA JAN
Officer
|
Sell | 87.2K | $7.1M |
| Mar 14, 2023 | MAKELA JAN
Officer
|
Sell | 70.6K | $5.5M |
| Aug 14, 2024 | STACHERSKI KENNETH ROBERT
Officer
|
Sell | 19.0K | $1.6M |
| Jul 31, 2023 | O'NEILL KEVIN MICHAEL
Officer
|
Sell | 15.6K | $1.2M |
| Nov 6, 2024 | ROTT ROLAND
Officer
|
Sell | 3.6K | $309.3K |
| May 28, 2024 | KASS-HOUT TAHA
Chief Technology Officer
|
Sell | 3.3K | $259.7K |
| Aug 7, 2024 | WESTRICK THOMAS J
Officer
|
Sell | 2.8K | $222.1K |
| Jun 8, 2023 | ROTT ROLAND
Officer
|
Sell | 2.5K | $191.3K |
| Feb 18, 2025 | NEWCOMB GEORGE A.
Officer
|
Sell | 2.0K | $185.1K |
| Nov 5, 2024 | RACKLIFFE PHILIP
Chief Executive Officer
|
Sell | 900 | $78.9K |
Page 1 of 1
Frequently Asked Questions
Is GE HealthCare Technologies Inc. (GEHC) stock a buy right now?
GE HealthCare Technologies Inc. (GEHC) is currently rated a 'Buy' by analysts, with a median price target of $83.00, suggesting a 29.5% upside from its current price of $64.07. Insider activity also indicates a moderate buy signal, with significant net purchases by insiders.
What is GEHC's stock price forecast for 2030?
Based on Monte Carlo simulations, GE HealthCare Technologies Inc. (GEHC) has a base case price projection of $71.48 for 2030, with a downside scenario of $30.46 and an upside scenario of $167.74. These are statistical outcomes, not guarantees.
How does GEHC's valuation compare to its sector peers?
GE HealthCare Technologies Inc. (GEHC) trades at a P/E ratio of 14.80 and a price-to-sales ratio of 1.36, which are significantly lower than the sector medians of 31.9 and 3.7, respectively, indicating a potentially attractive valuation.
What are the key technical indicators for GEHC stock?
GEHC's technical indicators show it is trading below its 50-day and 200-day moving averages ($68.26 and $72.42), with an oversold RSI at 4.3. This suggests bearish short-term momentum, but also potential for a reversal.
What is the recent earnings performance of GEHC?
GEHC recently reported an EPS beat for the quarter ending June 2026, with actual EPS of $2.84 versus an estimate of $2.80, leading to a 12.15% stock price increase. This follows a slight miss in the previous quarter.
What are the main risks facing GE HealthCare Technologies Inc. (GEHC)?
Key risks for GEHC include its current bearish technical trend, potential competitive pressures in the medical devices market, and the possibility of not meeting projected revenue growth targets.
What is the consensus rating among Wall Street analysts for GEHC?
Wall Street analysts have a consensus 'Buy' rating for GEHC, with 10 'Buy' ratings and 5 'Hold' ratings out of 19 total analysts. The average analyst price target is $82.50, with a median of $83.00.